Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation

Bone Marrow Transplantation

Volumn 32, Issue 10, 2003, Pages 1021-1026

  Yang, Hongyou ^a   Acker, J P ^a,b   Cabuhat, M ^a   McGann, L E ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cryopreservation; Hematopoietic progenitor cells; Viability

Indexed keywords

CD34 ANTIGEN; PROPIDIUM IODIDE; TRYPAN BLUE;

ARTICLE; CELL MEMBRANE; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CRYOPRESERVATION; FLUOROMETRY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INCUBATION TIME; MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TEMPERATURE; THAWING;

ANTIGENS, CD34; CELL SURVIVAL; CRYOPRESERVATION; HEMATOPOIETIC STEM CELLS; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TEMPERATURE; TIME;

EID: 0344465967     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704247     Document Type: Article

References (17)

1. Bender JG, To LB, Williams S et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1:329-341.
2. + cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transplantation 1997; 37: 1050-1057.
3. + cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967-972.
4. + determination in stem cell transplantation: before or after cryopreservation of grafts? J Hematother Stem Cell Res 2002;11: 429-435.
5. Mascotti K, McCullough J, Burger SR. HPC viability measurement: trypan blue versus acridine orange and propidium iodide. Transfusion 2000; 40: 693-696.
6. Yang H, Acker JP, Hannon J et al. Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001; 3:377-386.
7. + cell counts based on the ISHAGE guidelines. Cytometry 1998; 34: 61-70.
8. + cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 1003 1010.
9. Burger SR, Kadidlo D, McCullough J. Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor. Transfusion 1999; 39: 451-456.
10. Yang H, Acker J, Chen A et al. In situ assessment of cell viability. Cell Transplant 1998; 7: 443-451.
11. + enumeration. Transfusion Med 2000; 10: 67-75.
12. Bank HL, Schmehl ML. Parameters for evaluation of viability assays: accuracy, precision, specificity, sensitivity and standardization. Cryobiology 1989; 26: 203-211.
13. Reeb BA. Dye exclusion test for bone marrow viability. In: Areman EM, Deeg HJ, Sacher RA (eds). Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. F.A. Davis Company: New York, 1992, pp. 403-404.
14. Rowley SD, Zuehlsdorf M, Braine HG et al. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxyclophosphamide-purged bone marrow. Blood 1987; 70: 271 275.
15. Bishop MR, Anderson JR, Jackson JD et al. High dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994; 83: 610-616.
16. Crowley JP, Rene A, Valeri CR. The recovery, structure, and function of human blood leukocytes after freeze-preservation. Cryobioloqy 1974; 11: 395-409.
17. Armitage WJ, Mazur P. Toxic and osmotic effects of glycerol and human granulocytes. Am J Physiol 1984; 247: C382-C389.